Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma

Primary effusion lymphoma (PEL) is a highly aggressive B-cell malignancy that is closely associated with one of oncogenic viruses infection, Kaposi's sarcoma-associated herpesvirus (KSHV). PEL prognosis is poor and patients barely survive more than 6 months even following active chemotherapy in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncogene
Asıl Yazarlar: Dai, Lu, Lin, Zhen, Qiao, Jing, Chen, Yihan, Flemington, Erik K., Qin, Zhiqiang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578886/
https://ncbi.nlm.nih.gov/pubmed/28459467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.122
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller